Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01814696 · ClinicalTrials.gov registry record · NA
The Effect of the MedSentry System on Medication Adherence
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT01814696: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT01814696 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01814696, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The goal of this pilot study to evaluate the effect of the MedSentry system, a multi-faceted medication adherence device and reminder system, on medication adherence and clinical outcomes in heart-failure (HF) patients. We will also evaluate the usability and satisfaction derived from using this system. We hypothesize that: 1. The use of the MedSentry system will improve medication adherence in patients with a discharge diagnosis of HF. 2. The improvement in adherence correlates with fewer hospitalizations and emergency department (ED) visits. 3. The improvement in adherence correlates with better health-related quality of life.
Interventions
- DEVICE MedSentry System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01814696
The ClinicalTrials.gov registry entry for NCT01814696 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MedSentry System is the first listed.
NCT01814696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01814696 about?
NCT01814696 is a clinical study titled "The Effect of the MedSentry System on Medication Adherence". The goal of this pilot study to evaluate the effect of the MedSentry system, a multi-faceted medication adherence device and reminder system, on medication adherence and clinical outcomes in heart-failure (HF) patients. We will also evaluate the usability and satisfaction derived from using this sys...
What is the current status of trial NCT01814696?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2013-03. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01814696?
The interventions under investigation include: MedSentry System (DEVICE).
Who is sponsoring clinical trial NCT01814696?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.